H1 acquires data management company Ribbon Health

Photo: Joos Mind/Getty Images

Healthcare technology company H1 has acquired data management software company Ribbon Health for an undisclosed sum with a mix of cash and stock, the company said this week.

Ribbon's platform facilitates how patients find the right doctor across digital health and insurance platforms, H1 said.

H1 entered into the definitive agreement in December, which is expected to accelerate its expansion into the health plan, provider system and digital health sectors. 

Ribbon Health's platform will join the H1 family of products as H1 for Health Plans and Digital Health to provide insurers, providers and digital health companies with real-time provider data.

"Our platforms – and our visions – mesh perfectly," said Ribbon Health founder and CEO Nate Maslak. "By combining our comprehensive provider data and provider data management software with H1's clinical insights and global reach, we're giving individuals the information they need to get the best possible care."

WHAT'S THE IMPACT?

In conjunction with the acquisition, H1 is refining its portfolio, including the AI-powered H1 for Medical, which helps medical affairs teams identify and engage Key Opinion Leaders (KOLs) to promote adherence to evidence-based medicine.

H1 for Clinical, meanwhile, supports clinical teams in identifying sites, principal investigators (PIs) and participants while advancing diversity, equity and inclusion in the trial process; while H1 for Commercial accelerates patient access by facilitating the development and successful launch of new medical therapies and technologies.

The company has also onboarded Dr. Stephen Hahn to its Board of Directors. As FDA Commissioner from 2019-2021 under the Trump administration, Hahn oversaw regulatory affairs for COVID-19 and non-COVID-19-related areas, including therapeutics, vaccine development, medical devices, diagnostics and clinical trials. He currently serves as CEO of Harbinger Health, where he spearheads early-stage cancer detection.

"I'm excited to join H1's board at such a pivotal time in healthcare innovation," said Hahn. "H1's commitment to leveraging data and technology to improve healthcare access and outcomes aligns with my lifelong passion for advancing care and clinical research. I look forward to lending my skills to help H1 progress its mission."

THE LARGER TREND

H1 has earned recognition recently, including being named one of Forbes' Best Startup Employers and being listed in the 2024 New York Digital Health 100.

The company is backed by prominent investors including Altimeter, Goldman Sachs Asset Management and Flex Capital, and is ranked among Y Combinator's Top Private Companies.

Jeff Lagasse is editor of Healthcare Finance News.
Email: jlagasse@himss.org
Healthcare Finance News is a HIMSS Media publication.